Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA)
- PMID: 10759783
- PMCID: PMC1905611
- DOI: 10.1046/j.1365-2249.2000.01198.x
Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA)
Abstract
Synovial fluid (SF) levels of soluble CD23 (sCD23) were determined in 96 patients presenting with an inflammatory knee effusion (73 with RA and 23 with reactive arthritis (ReA) serving as a control inflammatory non-erosive group) and were correlated with the degree of joint destruction, with local immune parameters (IL-1beta, IL-3, IL-4, IL-6, IL-8, IL-10, IL-12 and sCD25) and with serum markers of inflammation, C-reactive protein and erythrocyte sedimentation rate. RA patients, classified as erosive or not according to Larsen's grade, were separated as follows: (i) 13 patients with non-erosive RA; (ii) 16 RA patients with erosions in hands but not in knees, matched for disease duration with the first group; (iii) 44 RA patients with hand and knee erosions, matched with the second group for rheumatoid factor positivity but of longer disease duration. SF sCD23 levels were significantly increased in both erosive RA groups compared with non-erosive diseases, whether RA or ReA (P < 0.05), whose SF levels were not different. SF IL-10 showed a similar profile to that of SF sCD23 and was the only other parameter characteristic of erosive RA, but no direct correlation was found between the two. SF sCD23 was significantly correlated with IL-12 (r = 0.65, P = 0.0001) and sCD25 (r = 0.39, P = 0.0019) exclusively in the two erosive RA populations. In conclusion, these data showing that increased levels of sCD23 are not only found in the SF of erosive joints but also in knee SF of patients with erosive RA but without knee x-ray-diagnosed erosions suggest that this parameter might be of predictive value for joint destruction. Longitudinal studies are however needed to confirm its potential clinical interest.
Figures



Similar articles
-
Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.J Rheumatol. 1995 Mar;22(3):406-12. J Rheumatol. 1995. PMID: 7783054
-
Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.Eur Cytokine Netw. 2000 Dec;11(4):669-76. Eur Cytokine Netw. 2000. PMID: 11125312
-
CD5 and CD23 expression on B cells in peripheral blood and synovial fluid of rheumatoid arthritis patients: relationship with interleukin-4, soluble CD23 and tumour necrosis factor alpha levels.Rheumatology (Oxford). 1999 Apr;38(4):325-8. doi: 10.1093/rheumatology/38.4.325. Rheumatology (Oxford). 1999. PMID: 10378709
-
Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from rheumatoid arthritis patients.BMC Musculoskelet Disord. 2015 Mar 12;16:51. doi: 10.1186/s12891-015-0516-3. BMC Musculoskelet Disord. 2015. PMID: 25879761 Free PMC article.
-
Receptor activator of nuclear factor kappa B ligand serum and synovial fluid level. A comparative study between rheumatoid arthritis and osteoarthritis.Rheumatol Int. 2012 Jun;32(6):1589-96. doi: 10.1007/s00296-011-1831-0. Epub 2011 Feb 17. Rheumatol Int. 2012. PMID: 21328055
Cited by
-
CD23/FcεRII: molecular multi-tasking.Clin Exp Immunol. 2010 Oct;162(1):12-23. doi: 10.1111/j.1365-2249.2010.04210.x. Clin Exp Immunol. 2010. PMID: 20831712 Free PMC article. Review.
-
ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo.J Exp Med. 2010 Mar 15;207(3):623-35. doi: 10.1084/jem.20091990. Epub 2010 Feb 15. J Exp Med. 2010. PMID: 20156974 Free PMC article.
-
Expression of ADAM15 in rheumatoid synovium: up-regulation by vascular endothelial growth factor and possible implications for angiogenesis.Arthritis Res Ther. 2005;7(6):R1158-73. doi: 10.1186/ar1796. Epub 2005 Aug 5. Arthritis Res Ther. 2005. PMID: 16277668 Free PMC article.
-
The emergence of ADAM10 as a regulator of lymphocyte development and autoimmunity.Mol Immunol. 2011 Jun;48(11):1319-27. doi: 10.1016/j.molimm.2010.12.005. Epub 2011 Jan 13. Mol Immunol. 2011. PMID: 21236490 Free PMC article. Review.
-
Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells.Immunol Cell Biol. 2015 Jan;93(1):77-85. doi: 10.1038/icb.2014.69. Epub 2014 Aug 26. Immunol Cell Biol. 2015. PMID: 25155463
References
-
- Delespesse G, Suter U, Mossalayi D, et al. Expression, structure and function of the CD23 antigen. Adv Immunol. 1991;49:149–91. - PubMed
-
- Delespesse G, Sarfati M, Wu CY, Fournier S, Letellier M. The low-affinity receptor for IgE. Immunol Rev. 1992;125:77–97. - PubMed
-
- Sarfati M, Fournier S, Wu CY, Delespesse G. Expression, regulation and function of human Fc epsilon RII (CD23) antigen. Immunol Res. 1992;11:260–72. - PubMed
-
- Liu YJ, Cairns JA, Holder MJ, Abbot SD, Jansen KU, Bonnefoy JY, Gordon J, MacLennan ICM. Recombinant 25-kDa CD23 and interleukin 1α promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol. 1991;21:1107–14. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials